These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30803987)

  • 1. An α
    Jing J; Sun Y
    J Biol Chem; 2019 Apr; 294(17):6670-6684. PubMed ID: 30803987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
    Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
    J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.
    Chen HH; Vicente CP; He L; Tollefsen DM; Wun TC
    Blood; 2005 May; 105(10):3902-9. PubMed ID: 15677561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Anti-Melanoma Activity of Novel Annexin V Derivative with β
    Zhu J; Li W; Jing J
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated α
    Kuo YJ; Chang YT; Chung CH; Chuang WJ; Huang TF
    Toxins (Basel); 2020 Jun; 12(7):. PubMed ID: 32605221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.
    Huang X; Ding WQ; Vaught JL; Wolf RF; Morrissey JH; Harrison RG; Lind SE
    Blood; 2006 Feb; 107(3):980-6. PubMed ID: 16195337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
    Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
    J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity.
    Kuypers FA; Larkin SK; Emeis JJ; Allison AC
    Thromb Haemost; 2007 Mar; 97(3):478-86. PubMed ID: 17334517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of osmotic shock and urea on phosphatidylserine scrambling in thrombocyte cell membranes.
    Gatidis S; Borst O; Föller M; Lang F
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C111-8. PubMed ID: 20237147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure.
    Shi J; Pipe SW; Rasmussen JT; Heegaard CW; Gilbert GE
    J Thromb Haemost; 2008 Jul; 6(7):1167-74. PubMed ID: 18485093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
    Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model.
    Thiagarajan P; Benedict CR
    Circulation; 1997 Oct; 96(7):2339-47. PubMed ID: 9337209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Antimalarial Tafenoquine on Blood Platelet Activity and Survival.
    Cao H; Bissinger R; Umbach AT; Al Mamun Bhuyan A; Lang F; Gawaz M
    Cell Physiol Biochem; 2017; 41(1):369-380. PubMed ID: 28214869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP; Chang JC; Chang HH; Tsai WJ; Lo SJ
    Biochem J; 2001 Jul; 357(Pt 1):57-64. PubMed ID: 11415436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
    Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
    Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved antithrombotic activity and diminished bleeding side effect of a PEGylated αIIbβ3 antagonist, disintegrin.
    Hsu CC; Chuang WJ; Chung CH; Chang CH; Peng HC; Huang TF
    Thromb Res; 2016 Jul; 143():3-10. PubMed ID: 27161326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.